Roivant Sciences Ltd (ROIV)

Quick ratio

		Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash	US$ in thousands	2,715,410	6,535,710	1,676,810	2,060,400	2,055,040
Short-term investments	US$ in thousands	2,171,480	5,367	5,011	13,634	77,701
Receivables	US$ in thousands	—	82,813	37,644	6,732	13,832
Total current liabilities	US$ in thousands	149,411	266,758	272,448	184,367	218,961
Quick ratio		32.71	24.83	6.31	11.29	9.80

March 31, 2025 calculation

Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($2,715,410K + $2,171,480K + $—K) ÷ $149,411K
= 32.71

The quick ratio of Roivant Sciences Ltd provides insights into the company's ability to meet its short-term obligations using its most liquid assets. The trend analysis of the quick ratio over the past five years reveals fluctuations in liquidity position:

1. As of March 31, 2021, the quick ratio was 9.80, indicating that the company had a strong ability to cover its current liabilities with its quick assets.

2. By March 31, 2022, the quick ratio improved to 11.29, suggesting a further enhancement in the company's liquidity position.

3. The quick ratio dropped to 6.31 as of March 31, 2023, indicating a decrease in the company's ability to cover its short-term obligations with quick assets.

4. There was a significant improvement in liquidity by March 31, 2024, with the quick ratio surging to 24.83. This indicates a robust liquidity position and the ability to meet short-term liabilities comfortably.

5. Unfortunately, no data is available for March 31, 2025, which limits the ability to assess the liquidity position for that period.

Overall, the quick ratio of Roivant Sciences Ltd has demonstrated some fluctuations over the years, with varying levels of liquidity. Investors and stakeholders should monitor these ratios closely to assess the company's ability to meet its short-term obligations effectively.